Fig. 3: Impact of A-STEP Recommendations on 2-Year Progression-Free Survival. | Nature Communications

Fig. 3: Impact of A-STEP Recommendations on 2-Year Progression-Free Survival.

From: Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC

Fig. 3

Comparison of 2-year progression-free survival (PFS) stratified by (I) actual treatment plans (received, REC) and (II) treatment plans recommended by A-STEP (RECOM). Subfigures (a–d) and (e–h) represent the discovery and external validation cohorts, respectively. P-values were calculated using the two-sided log-rank test. Hazard ratios (HRs) and 95% confidence intervals (CIs) are shown, with the anti-recommendation group used as the reference. Source data are provided as a Source Data file.

Back to article page